Back to results
US 7,417,175 B2Granted
Interstitial prostatism model animal
AssigneeTaiho Pharmaceuticals Co., Ltd.
InventorsNobuyuki Oda, Kazuhisa Miyoshi, Akihiro Haruno, Hidekazu Miyake
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeTaiho Pharmaceuticals Co., Ltd.
InventorsNobuyuki Oda, Kazuhisa Miyoshi, Akihiro Haruno, Hidekazu Miyake
Estimating the term…
The present invention provides an animal model for prostatic stromal hyperplasia, and a method for screening for a substance effective for preventing/treating human benign prostatic hyperplasia using the animal model. The animal model for prostatic stromal hyperplasia is produced by implanting the fetal urogenital sinus of a non-human animal under the skin or beneath the prostatic capsule of a non-human animal belonging to the species of the same as or different from the animal. A substance effective for preventing/treating human benign prostatic hyperplasia can be screened by administering a test substance to the animal model and measuring the preventive or therapeutic effect of the test substance upon the implanted tissue (fetal urogenital sinus or tissue derived therefrom).
A mouse or rat model for prostatic stromal hyperplasia comprising a rat or mouse having an implanted fetal urogenital sinus from a donor mouse or rat implanted directly beneath the prostatic capsule, but not within the prostate gland, wherein said rat or mouse is genetically immunodeficient or is syngeneic to the mouse or rat from which the extraneous fetal urogenital sinus was obtained and wherein said mouse or rat exhibits prostatic stromal hyperplasia.
A method for producing a rat or mouse model for prostatic stromal hyperplasia comprising:
Dependencies are inferred from the claim text.